The Riskalyze Report: Advisors Flee from European Stocks

At the request of so many investment advisors, my friends at Riskalyze share the big trends in the assets going into and coming out of advisor portfolios every week. The underlying data is aggregated from hundreds of thousands of client accounts across the $120 billion and counting that advisors manage on the Riskalyze platform*. I hope we can uncover interesting trends for you each week…


June 26th – July 2nd

Winners (advisor flows TO these investments increased substantially):
  1. International Bonds (BNDX)
  2. US Bond (DFAPX)
  3. Cash

Losers (advisor flows FROM these investments increased substantially):

  1. Europe (VGK)
  2. International Stocks (EFA)
  3. Hedged Europe (HEDJ)

Josh here – the aftermath of the Brexit vote had financial advisors in the mood to blow out of European exposure, and international stocks more generally.

Here’s Riskalyze CIO Mike McDaniel with the details: “Week over week change for losers was significant with advisor use of the aforementioned losers decreasing by over 28% week over week. Changes to winners was insignificant by comparison. Advisor use of VGK decreased by over 50% week over week (that’s not a typo).”


(to state the obvious, Riskalyze does not share client sensitive data with me or use animals in testing).

This content, which contains security-related opinions and/or information, is provided for informational purposes only and should not be relied upon in any manner as professional advice, or an endorsement of any practices, products or services. There can be no guarantees or assurances that the views expressed here will be applicable for any particular facts or circumstances, and should not be relied upon in any manner. You should consult your own advisers as to legal, business, tax, and other related matters concerning any investment.

The commentary in this “post” (including any related blog, podcasts, videos, and social media) reflects the personal opinions, viewpoints, and analyses of the Ritholtz Wealth Management employees providing such comments, and should not be regarded the views of Ritholtz Wealth Management LLC. or its respective affiliates or as a description of advisory services provided by Ritholtz Wealth Management or performance returns of any Ritholtz Wealth Management Investments client.

References to any securities or digital assets, or performance data, are for illustrative purposes only and do not constitute an investment recommendation or offer to provide investment advisory services. Charts and graphs provided within are for informational purposes solely and should not be relied upon when making any investment decision. Past performance is not indicative of future results. The content speaks only as of the date indicated. Any projections, estimates, forecasts, targets, prospects, and/or opinions expressed in these materials are subject to change without notice and may differ or be contrary to opinions expressed by others.

Wealthcast Media, an affiliate of Ritholtz Wealth Management, receives payment from various entities for advertisements in affiliated podcasts, blogs and emails. Inclusion of such advertisements does not constitute or imply endorsement, sponsorship or recommendation thereof, or any affiliation therewith, by the Content Creator or by Ritholtz Wealth Management or any of its employees. Investments in securities involve the risk of loss. For additional advertisement disclaimers see here:

Please see disclosures here.

What's been said:

Discussions found on the web
  1. kalpa pharma clenbuterol reviews commented on Oct 08

    … [Trackback]

    […] Information on that Topic: […]

  2. rbc canada commented on Dec 04

    … [Trackback]

    […] There you can find 15459 additional Info to that Topic: […]

  3. CI-CD commented on Dec 20

    … [Trackback]

    […] Read More on on that Topic: […]